These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 12699444

  • 1. Long-term follow-up of bone mineral density in Addison's disease.
    Jódar E, Valdepeñas MP, Martinez G, Jara A, Hawkins F.
    Clin Endocrinol (Oxf); 2003 May; 58(5):617-20. PubMed ID: 12699444
    [Abstract] [Full Text] [Related]

  • 2. Bone density and turnover in Addison's disease: effect of glucocorticoid treatment.
    Valero MA, Leon M, Ruiz Valdepeñas MP, Larrodera L, Lopez MB, Papapietro K, Jara A, Hawkins F.
    Bone Miner; 1994 Jul; 26(1):9-17. PubMed ID: 7950508
    [Abstract] [Full Text] [Related]

  • 3. Predictors of bone mineral density in patients receiving glucocorticoid replacement for Addison's disease.
    Furman K, Gut P, Sowińska A, Ruchała M, Fichna M.
    Endocrine; 2024 May; 84(2):711-719. PubMed ID: 38334892
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
    Camozzi V, Betterle C, Frigo AC, Zaccariotto V, Zaninotto M, De Caneva E, Lucato P, Gomiero W, Garelli S, Sabbadin C, Salvà M, Costa MD, Boscaro M, Luisetto G.
    Endocrine; 2018 Feb; 59(2):319-329. PubMed ID: 28795340
    [Abstract] [Full Text] [Related]

  • 7. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
    Lane NE, Sanchez S, Genant HK, Jenkins DK, Arnaud CD.
    Osteoporos Int; 2000 Feb; 11(5):434-42. PubMed ID: 10912846
    [Abstract] [Full Text] [Related]

  • 8. Bone metabolism, density, and geometry in postmenopausal women with vitamin D insufficiency: a cross-sectional comparison of the effects of elevated parathyroid levels.
    Rødbro LL, Bislev LS, Sikjær T, Rejnmark L.
    Osteoporos Int; 2018 Oct; 29(10):2211-2218. PubMed ID: 29955908
    [Abstract] [Full Text] [Related]

  • 9. Parathyroidectomy for primary hyperparathyroidism induces positive uncoupling and increases bone mineral density in cancellous bones.
    Abe Y, Ejima E, Fujiyama K, Kiriyama T, Ide A, Sera N, Tominaga T, Ashizawa K, Yokoyama N, Eguchi K.
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):203-9. PubMed ID: 10671948
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Introduction: Patients with primary adrenal insufficiency receive long - term glucocorticoid replacement therapy, which may cause osteoporosis].
    Vaňuga P, Ságová I.
    Vnitr Lek; 2021 Feb; 67(5):264-269. PubMed ID: 35459392
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy.
    Diamond T, Campbell J, Bryant C, Lynch W.
    Cancer; 1998 Oct 15; 83(8):1561-6. PubMed ID: 9781950
    [Abstract] [Full Text] [Related]

  • 15. Bone mineral density in patients with treated Addison's disease.
    Braatvedt GD, Joyce M, Evans M, Clearwater J, Reid IR.
    Osteoporos Int; 1999 Oct 15; 10(6):435-40. PubMed ID: 10663342
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relationship between increased endogenous parathormone levels and bone density in postmenopausal women treated with bisphosphonates.
    Coin A, Veronese N, Bolzetta F, De Rui M, Manzato E, Sergi G.
    Panminerva Med; 2012 Dec 15; 54(4):277-82. PubMed ID: 23123579
    [Abstract] [Full Text] [Related]

  • 20. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.
    Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M, Ohi H.
    Calcif Tissue Int; 2000 Mar 15; 66(3):195-9. PubMed ID: 10666494
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.